BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9805	Companies
196647	Keywords
127661	Articles
104550	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 12/09/2024 at 09:05, 1 year 1 month ago

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
BioNxt Solutions Inc. achieves key milestones in the development of BNT23001, a sublingual thin-film formulation of Cladribine for Multiple Sclerosis treatment, paving the way for clinical trials and regulatory submissions in 2025

Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Sublingual Thin-Film BNT23001
BRIEF

published on 12/02/2024 at 09:10, 1 year 2 months ago

BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide

Drug Delivery Innovation BioNxt Solutions Patient Compliance Sublingual Thin-Film Semaglutide
BRIEF

published on 12/02/2024 at 09:10, 1 year 2 months ago

BioNxt Solutions développe un film mince sublingual pour le sémaglutide

Solutions BioNxt Conformité Des Patients Semaglutide Couche Mince Sublinguale Innovation Dans L'administration Des Médicaments
PRESS RELEASE

published on 12/02/2024 at 09:05, 1 year 2 months ago

BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
BioNxt Solutions Inc. introduces sublingual thin-film oral dissolvable film (ODF) for Semaglutide, enhancing patient experience and improving drug delivery

Innovation Healthcare BioNxt Solutions Inc. Drug Delivery Semaglutide
BRIEF

published on 11/25/2024 at 09:10, 1 year 2 months ago

BioNxt Expands Sublingual Product Pipeline with Innovations

BioNxt Solutions Sublingual Technology Autoimmune Treatments Longevity Market Drug Delivery Systems
BRIEF

published on 11/25/2024 at 09:10, 1 year 2 months ago

BioNxt élargit sa gamme de produits sublinguaux avec des innovations

Solutions BioNxt Technologie Sublinguale Traitements Auto-immuns Marché De La Longévité Systèmes D'administration De Médicaments
PRESS RELEASE

published on 11/25/2024 at 09:05, 1 year 2 months ago

BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity
BioNxt Solutions Inc. expands next-gen product pipeline targeting autoimmune diseases & longevity market. Innovative drug delivery systems show promise in major high-growth markets

BioNxt Solutions Inc. Next-Generation Technologies Autoimmune Diseases Longevity Market Drug Delivery Systems
BRIEF

published on 10/29/2024 at 08:10, 1 year 3 months ago

BioNxt Advances Patent Filings for Novel Drug Delivery

Multiple Sclerosis Patent Filings BioNxt Solutions Myasthenia Gravis Sublingual Drugs
BRIEF

published on 10/29/2024 at 08:10, 1 year 3 months ago

BioNxt avance dans ses démarches de dépôt de brevets pour un nouveau mode d'administration de médicaments

Sclérose En Plaques Solutions BioNxt Myasthénie Grave Médicaments Sublinguaux Dépôts De Brevets
PRESS RELEASE

published on 10/29/2024 at 08:05, 1 year 3 months ago

BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases
BioNxt Solutions Inc. initiates nationalization process for sublingual anticancer drug patents for autoimmune neurodegenerative diseases. Positive report from European Patent Office on patentability

BioNxt Solutions Inc. Patents Anticancer Drugs Sublingual Delivery Autoimmune Neurodegenerative Diseases

Accesswire

Published on 02/05/2026 at 01:35, 1 hour 41 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 3 hours 16 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 4 hours 51 minutes ago

55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 18:00, 9 hours 16 minutes ago

Lithium South AGSM Update
Published on 02/04/2026 at 16:15, 11 hours 1 minute ago

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 20:54, 6 hours 22 minutes ago

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 6 hours 40 minutes ago

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 7 hours 16 minutes ago

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 8 hours 21 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 8 hours 36 minutes ago

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology

Les Echos

Published on 02/04/2026 at 18:04, 9 hours 12 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 9 hours 12 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 9 hours 31 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 9 hours 31 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 02/04/2026 at 17:45, 9 hours 31 minutes ago

Janvier 2026

View all LES ECHOS COMFI WIRE